SELF-STIGMA AND ITS INFLUENCE ON EMPLOYMENT PROSPECTS FOR INDIVIDUALS LIVING WITH SCHIZOPHRENIA

Authors

  • Alexandra Papadopoulos Occupational therapist, Psychiatric Hospital of Attica, Greece.
  • Andreas Nikolaou Hellenic Open University, Greece.
  • Maria Ioannou Department of Psychology, University of Crete, Gallos’ University Campus, Rethymno, 74100, Greece

DOI:

https://doi.org/10.5281/zenodo.14779292

Keywords:

mental illness, schizophrenia, self-stigmatization, psychopharmaceuticals, community living, recovery 1. Introduction: mental illness and self

Abstract

Mental illnesses encompass a spectrum of symptoms affecting cognition, emotion, communication, and behavior, with schizophrenia being a severe example leading to self-stigmatization and reduced self-esteem. Scientific advancements have revolutionized psychiatric treatment by introducing various psychopharmaceuticals, facilitating the deinstitutionalization of mentally ill individuals. Chlorpromazine's discovery in 1950 was a significant milestone in schizophrenia treatment, contributing to community living. However, successful reintegration into daily life depends on numerous factors beyond medication. This article examines the multifaceted aspects of living with schizophrenia in the post-asylum era and highlights the complex nature of recovery.

Downloads

Published

2025-01-31

Issue

Vol. 12 No. 4 (2024)

Section

Articles